Tata Capital on Monday declared that a Rs 955 crore fundraise by a private equity arm for investing in healthcare companies. The Tata Capital Healthcare Fund II attained a final closure of its fund with investor commitments of Rs 955 crore or USD
The Telangana government on Sunday said US-based complex generic and specialty drugs player, Slayback Pharma, will be capitalizing $ 20 million towards expansion of its operations in Hyderabad over the next three years.
The Serum Institute has applied to the Drugs Controller General of India seeking emergency use authorisation for its recombinant BCG (rBCG) vaccine for the prevention.
Prices of around 800 essential medicines comprising antibiotics, anti-infective and painkillers are set to rise from April, as the government has allowed an increase of over 10 per cent for the scheduled drugs.
he Central government has informed the Rajya Sabha that Pakistani pharmaceutical importers held back the payment of $430,000 of Indian exporters for pharmaceutical products exported to Pakistan from April to December 2021.
The inaugural session of the two-day FE Pharma Summit 2022 that began on Thursday, March 24th, focused on the theme of transitioning India from being the pharmacy of the world to evolving as an innovation hub.
The pharmaceutical industry has a substantial impact on the environment, especially when the materials used to make them and the chemicals that comprise make their way directly into the environment.
The Drugs Controller General of India (DCGI) granted permission on Wednesday for conducting the phase-3 clinical trial of COVID-19 vaccine Covovax as a booster dose in adults, official sources said. The Subject Expert Committee (SEC) on COVID-19 .
Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.
Health tech startup FutureCure Health has secured around USD 4 million (about Rs 30.4 crore) in series A funding round from RVCF India Growth Fund, Unicorn India Ventures, Kotak Investment Advisor Limited, and other investors,
, CDSCO.jpg)
